The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The Integrin α9β1 Binds to a Novel Recognition Sequence (SVVYGLR) in the Thrombin-cleaved Amino-terminal Fragment of Osteopontin
Open accessAbstract
The integrin alpha(9)beta(1) mediates cell adhesion to tenascin-C and VCAM-1 by binding to sequences distinct from the common integrin-recognition sequence, arginine-glycine-aspartic acid (RGD). A thrombin-cleaved NH(2)-terminal fragment of osteopontin containing the RGD sequence has recently been shown to also be a ligand for alpha(9)beta(1). In this report, we used site-directed mutagenesis and synthetic peptides to identify the alpha(9)beta(1) recognition sequence in osteopontin. alpha(9)-transfected SW480, Chinese hamster ovary, and L-cells adhered to a recombinant NH(2)-terminal osteopontin fragment in which the RGD site was mutated to RAA (nOPN-RAA). Adhesion was completely inhibited by anti-alpha(9) monoclonal antibody Y9A2, indicating the presence of a non-RGD alpha(9)beta(1) recognition sequence within this fragment. Alanine substitution mutagenesis of 13 additional conserved negatively charged amino acid residues in this fragment had no effect on alpha(9)beta(1)-mediated adhesion, but adhesion was dramatically inhibited by either alanine substitution or deletion of tyrosine 165. A synthetic peptide, SVVYGLR, corresponding to the sequence surrounding Tyr(165), blocked alpha(9)beta(1)-mediated adhesion to nOPN-RAA and exposed a ligand-binding-dependent epitope on the integrin beta(1) subunit on alpha(9)-transfected, but not on mock-transfected cells. These results demonstrate that the linear sequence SVVYGLR directly binds to alpha(9)beta(1) and is responsible for alpha(9)beta(1)-mediated cell adhesion to the NH(2)-terminal fragment of osteopontin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191
Integrins and Signal Transduction Pathways: the Road Taken
Clark, E. A., & Brugge, J. S. (1995) · Science · doi:10.1126/science.7716514 · Cited by 2,937
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Self-citationOsteopontin: a protein with diverse functions
Denhardt, D. T., & Guo, X. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.15.8262332 · Cited by 1,078
Crystal structure of the A domain from the a subunit of integrin CR3 (CD11 b/CD18)
Lee, J.-O., Rieu, P., Arnaout, M. A., & Liddington, R. (1995) · Cell · doi:10.1016/0092-8674(95)90517-0 · Cited by 887
Liaw, L., Skinner, M. P., Raines, E. W., Ross, R., Cheresh, D. A., Schwartz, S. M., & Giachelli, C. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117718 · Cited by 512
Novel purification of vitronectin from human plasma by heparin affinity chromatography.
Yatohgo, T., Izumi, M., Kashiwagi, H., & Hayashi, M. (1988) · Cell Structure and Function · doi:10.1247/csf.13.281 · Cited by 510
O'Brien, E. R., Garvin, M. R., Stewart, D. K., Hinohara, T., Simpson, J. B., Schwartz, S. M., & Giachelli, C. M. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1648 · Cited by 320
Taooka, Y., Chen, J., Yednock, T., & Sheppard, D. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.2.413 · Cited by 261
Self-citation
Cited by
Denhardt, D. T., Noda, M., O’Regan, A. W., Pavlin, D., & Berman, J. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12980 · Cited by 1,059
Osteopontin: role in cell signaling and cancer progression
Rangaswami, H., Bulbule, A., & Kundu, G. C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.12.005 · Cited by 735
Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease
Scatena, M., Liaw, L., & Giachelli, C. M. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.144824 · Cited by 644
Osteopontin: a versatile regulator of inflammation and biomineralization
Giachelli, C. M., & Steitz, S. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00108-6 · Cited by 583
Ren, X., Feng, Y., Guo, J., Wang, H., Li, Q., Yang, J., Hao, X., Lv, J., Ma, N., & Li, W. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00483c · Cited by 573
Immune microenvironment of gliomas
Gieryng, A., Pszczolkowska, D., Walentynowicz, K. A., Rajan, W. D., & Kaminska, B. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.19 · Cited by 538
Mesenchymal stem cells: key players in cancer progression
Ridge, S. M., Sullivan, F. J., & Glynn, S. A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0597-8 · Cited by 526
The role of osteopontin in inflammatory processes
Lund, S. A., Giachelli, C. M., & Scatena, M. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0068-0 · Cited by 516
Agnihotri, R., Crawford, H. C., Haro, H., Matrisian, L. M., Havrda, M. C., & Liaw, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103608200 · Cited by 414
The role of Osteopontin in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.03.028 · Cited by 365
Osteopontin: a key cytokine in cell‐mediated and granulomatous inflammation
O'Regan, A., & Berman, J. S. (2000) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2000.00163.x · Cited by 357
Role of Osteopontin in Cellular Signaling and Toxicant Injury
Denhardt, D. T., Giachelli, C. M., & Rittling, S. R. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.723 · Cited by 349
Integrin-α9 Is Required for Fibronectin Matrix Assembly during Lymphatic Valve Morphogenesis
Bazigou, E., Xie, S., Chen, C., Weston, A., Miura, N., Sorokin, L., Adams, R., Muro, A. F., Sheppard, D., & Makinen, T. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.017 · Cited by 347
Self-citationOsteopontin: regulation in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9104-9 · Cited by 321
Fatal Bilateral Chylothorax in Mice Lacking the Integrin α9β1
Huang, X. Z., Wu, J. F., Ferrando, R., Lee, J. H., Wang, Y. L., Farese, R. V., & Sheppard, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5208-5215.2000 · Cited by 286
Self-citationThe metastasis gene osteopontin: a candidate target for cancer therapy
Weber, G. F. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00037-3 · Cited by 286
Adhesion receptors of vascular smooth muscle cells and their functions
Moiseeva, E. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00399-6 · Cited by 282
Kazanecki, C. C., Uzwiak, D. J., & Denhardt, D. T. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21558 · Cited by 275
Azadi, S., Yazdanpanah, M. A., Afshari, A., Alahdad, N., Chegeni, S., Angaji, A., Rezayat, S. M., & Tavakol, S. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241303818 · Cited by 24
Osteopontin in Cancer: Mechanisms and Therapeutic Targets
Kariya, Y., & Kariya, Y. (2022) · International Journal of Translational Medicine · doi:10.3390/ijtm2030033 · Cited by 14
Metadata
- Authors
- Yokosaki, Y., Matsuura, N., Sasaki, T., Murakami, I., Schneider, H., Higashiyama, S., Saitoh, Y., Yamakido, M., Taooka, Y., & Sheppard, D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-12
- Volume
- 274
- Issue
- 51
- Pages
- 36328-36334
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2013326206
- Cited by
- 305
- References
- 30
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.